1. Results obtained during claims substantiation study performed in June 2022 and May 2023 by Use-Lab GmbH, an independent company. Based on responses from 25 physicians from the EU and the US, who answered a questionnaire after a usability study with additional hands-on time with the system.
2. Results obtained during claims substantiation study performed in June 2022 and May 2023 by Use-Lab GmbH, an independent company. Response is based on 44 clinicians from the EU and the US, who answered a questionnaire after a usability study with additional hands-on time with the system.
3. Results obtained during claims substantiation study performed in June 2022 and May 2023 by Use-Lab GmbH, an independent company. Response is based on 49 clinicians from the EU and the US, who answered a questionnaire after a usability study with additional hands-on time with the system.
4. Results obtained during user tests performed in November 2013 by Use-Lab GmbH, an independent company. The tests involved 30 USA-based clinicians (15 physicians teamed up with 15 nurses or X-ray technicians), who performed simulated procedures using Philips mobile X–ray systems in a simulated OR environment. None of them had worked with each other before.
The X-ray dose reductions refer to specific features and will vary depending on the dose parameters selected.
Some clinical images shown are from Zenition 70 and Veradius Unity and do not represent the final image quality of the Zenition 90.
Zenition 90 systems are available for sale in a limited number of countries. Please check with your local Philips representative.
Some features shown are optional for Zenition 90.
Actual product representation may vary.
ㅤ